期刊文献+

SDF-1α促进乳腺癌细胞CerbB-2蛋白的表达

SDF-1α stimulates expression of CerbB-2 in human breast carcinoma MCF-7 cells
暂未订购
导出
摘要 目的:探讨SDF-1α对乳腺癌细胞CerbB-2表达的影响。方法:SDF-1α与乳腺癌细胞MCF-7共培养,Western印迹法检测CerbB-2的表达差异;裸鼠成瘤实验联合免疫组织化学法检测SDF-1α在体内对乳腺癌细胞CerbB-2表达的影响;细胞迁徙及失巢凋亡实验对比分析SDF-1α对乳腺癌MCF-7细胞体外迁徙及抗失巢凋亡能力的影响。结果:Western印迹及裸鼠成瘤免疫组织化学检测结果显示,在体内体外SDF-1均能显著提高CerbB-2的表达,3组经不同浓度SDF-1α刺激的MCF-7细胞CerbB-2蛋白表达量均较空白对照组明显增高,其中400ng/mL组升高最为明显。侵袭小室实验发现,SDF-1α可明显增强乳腺癌MCF-7细胞株的细胞变形迁徙和侵袭破坏能力,培养6h后迁徙进入微孔膜的细胞数比阴性对照组显著增多[(172.27±9.72)vs(128.63±13.72),P<0.01];SDF-1α+MCF-7细胞发挥破坏Matrigel基质胶作用,进入微孔膜内的细胞数也高于MCF-7细胞[(52.28±9.24)vs(17.21±2.89),P<0.01]。悬浮培养的SDF-1α+MCF-7细胞比MCF-7细胞更容易聚集,形成相对致密的细胞团;200、400、800ng/mLSDF-1α作用24h后,MCF-7细胞的凋亡率分别为(9.72±1.11)%、(8.64±1.22)%和(10.36±1.31)%,与阴性对照组(18.41±1.71)%的差异有统计学意义(P<0.01)。结论:SDF-1α可显著提高乳腺癌细胞MCF-7的CerbB-2表达,拓宽了靶向药物Herceptin的应用范围。 Objective:To investigate the effect of SDF-1 α on the expression of CerbB-2 on the surface of human breast carcinoma MCF-7 cells. Methods:SDF-1α was co-cultured with human breast carcinoma MCF-7 cells. Expression of CerbB-2 in MCF-7 cells was detected by Western blotting in vitro. Nude mice tumorigenesis test and immunohistochemistry ( IHC ) were used to observe the effect of SDF-1α on the expression of CerbB-2 in vivo. The metastatic ability of MCF-7 cells was analyzed by Transwell migration test. The apoptosis of MCF-7 cells was detected by anoikis-resistant apoptosis assay. Results:Western blotting,nude mice tumorigenesis test and IHC showed that expression of CerbB-2 protein was significantly upregulated in human breast carcinoma MCF-7-cells after SDF-1α stimulation at three different concentrations. The effect was the strongest at SDF-1α 400 ng/mL. Transwell chamber test demonstrated that the migration and invation capabilities of MCF-7 cells were enhanced by co-culture with SDF-1α. After co-culture for 6 h, the cells migrating into micro-membrane were greatly increased compared with negative control [ ( 172.27 ±9.72) vs ( 128.63 ± 13.72) , P 〈0.01]. The MCF-7 cells exerted damaging effects on Matrigel after co-euhure with SDF-1α. The cells invading Matrigel were markedly elevated [ ( 52.28 ± 9.24) vs ( 17.21± 2.89), P 〈 0.01 ]. Suspended MCF-7 ceils co-cultured with SDF-1α tended to accumulate thus forming relatively dense cell clusters. Apoptosis index (AI) of MCF-7 cells was (9.72 ±1.11 ) % , ( 8.64 ± 1.22) % , and ( 10.36 ±1.31 ) % after coulture with SDF-1α at 200,400, and 800 ng/mL compared with control group ( 18.41% ± 1.71% ). Conclusion: SDF-1α significantly elevates the expression of CerbB-2 on the surface of breast carcinoma MCF-7 cells and widens the application area of targeting drug Herceptin.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第4期329-333,共5页 Tumor
关键词 乳腺肿瘤 超化因子 CXC 受体 ERBB-2 基因表达 细胞运动 细胞凋亡 Breast neoplasms Chemokines, CXC Receptor, erbB-2 Gene expression Cell movement Apoptosis
  • 相关文献

参考文献11

  • 1华兴,王峰,莫雪梅,李秀英,张光,许华,孙晗笑.vMIP-II对细胞表面趋化因子受体CXCR4内化及调变的研究[J].现代免疫学,2006,26(3):213-216. 被引量:4
  • 2HUJANEN ES, TERRANOVA VP. Migration of tumor cells to organ-derived chemoattractants [ J]. Cancer Res, 1985,45 ( 8 ) :3517- 3521.
  • 3FRISCH S M, FRANCIS H. Disruption Of epithelial cell-matrix interactions induces apoptosis [ J ]. Cell Biol, 1994,124 ( 4 ) : 619- 626.
  • 4FRISCH S M, SCREATON R A. Anoikis mechanisms [ J ]. Curr Opin Cell Biol,2001,13 ( 5 ) :555-562.
  • 5黄伟翼,靖大道,沈赞.siRNA沉默PI3K基因激活FoxO3a基因并抑制人乳腺癌裸鼠移植瘤生长的实验研究[J].肿瘤,2008,28(4):310-312. 被引量:5
  • 6WIDAKOWICH C, DINH P, DE AZAMBUJA E, et al. HER-2 positive breast cancer: what else beyond trastuzumab-based therapy [ J ]. Anticancer Agents Med Chem, 2008,2 ( 5 ) :488 -496.
  • 7NAHTA R, YU D, HUNGM C, et al. Mechanisms of disease:understanding resistance to HER2-targeted therapy in human breast cancer [ J ]. Nat Clin Pract Oncol,2006, 3 ( 5 ) : 269-280.
  • 8GONZALEZ-ANGULO A M, HORTOBAGYI G N, ESTEVA F J. Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer[ J ]. Oncologist, 2006, 11 (8) : 857-867.
  • 9DE LAURENTIIS M, CANCELLO G, ZINNO L, et al. Targeting HER2 as a therapeutic strategy for breast cancer: a paradimatic shift of drug development in oncology [ J ]. Ann Oncol, 2005,16 (Suppl4) : 7-13.
  • 10LOESCH D, ASMAR L, MCINTYRE K, et al. Phase Ⅱ trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer[ J]. Clin Breast Cancer, 2008 ,4(2) :178-186.

二级参考文献20

  • 1华兴,陈宏,张光,刘俊云,孙晗笑.重组病毒巨噬细胞炎性蛋白致畸胎研究及骨髓微核实验[J].中国新药与临床杂志,2005,24(1):53-56. 被引量:3
  • 2Kledal TN,Rosenkilde MM,Coulin F,et al.A broadspectrum chemokine antagonist encoded by Kaposis sarcoma-associated herpesvirus[J].Science,1997,277(5332):1656-1659.
  • 3John PM,Robert WD.The entry of inhibitors:a fusion of science and medicine[J].Proc Natl Acad Sci USA,2003,100(19):10598-10602.
  • 4Boshoff C,Endo Y,Collins PD,et al.Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines[J].Science,1997,278(5336),290-294.
  • 5Shao W,Fernandez E,Sachpatzidis A,et al.CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structureE[J].Eur J Biochem,2001,268(10),2948-2959.
  • 6Lum JJ,Schnepple DJ,Badley AD.Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions[J].AIDS,2005,19(11):1125-1133.
  • 7Bryen AJ,Lakshmi AD.G-protein-coupled receptor heterodimerizatioin modulates receptor function[J].Nature,1999,399(17):697-700.
  • 8Joly M,Pinto JM.CXCR4 and CCR5 regulation and expression patterns on T-and monocyte-macrophage cell lineages.implications for susceptibility to infection by HIV-1[J].Math Biosci,2005,195(1),92-126.
  • 9Barrett JR,Alfred W,Marco B.Recombinant human MCP-1/JE induces chemotaxis,calcium flux,and the respiratory burst in human monocytes[J].Blood,1991,178(4),1112-1116.
  • 10Tran PB,Ren D,Miller RJ.The HIV-1 coat protein gp120 regulates CXCR4-mediated signaling in neural progenitor cells[J].J Neuroimmunol,2005,160(1-2),68-76.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部